Cargando…
Exposure to anticancer drugs modulates the expression of ACSL4 and ABCG2 proteins in adrenocortical carcinoma cells
Adrenocortical carcinoma (ACC) is a rare and malignant disease, with more than 50 % of patients developing hormone-secreting tumors. These tumors are genetically heterogeneous and potentially lethal, as metastasis is often underway at the time of diagnosis. While chemoresistance can be multifactoria...
Autores principales: | Ríos Medrano, Mayra Agustina, Bigi, María Mercedes, Martínez Ponce, Paloma, Podesta, Ernesto Jorge, Orlando, Ulises Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585233/ https://www.ncbi.nlm.nih.gov/pubmed/37867801 http://dx.doi.org/10.1016/j.heliyon.2023.e20769 |
Ejemplares similares
-
ABCG2 transports anticancer drugs via a closed-to-open switch
por: Orlando, Benjamin J., et al.
Publicado: (2020) -
ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
por: Yang, Yufei, et al.
Publicado: (2022) -
ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
por: Hou, Jun, et al.
Publicado: (2022) -
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancer
por: Fernández, Lara Paula, et al.
Publicado: (2020) -
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases
por: Ndiaye, Haarith, et al.
Publicado: (2020)